Whalegun
Home

Matthew B. Klein, CEO: PTC Therapeutics PTCT Sell · Filed 25/02/21

Trade details

Type
Insider sale
Amount
$195,239.7
Shares · price
3,897 sh · $50.10 a share
Held after
279,933 sh
Stock
PTC Therapeutics PTCT
Person
Matthew B. KleinCEO
Trade date
25/02/19
Filed
25/02/21
Days to filing
2 days

Sold 1.4% of holdings

Share of holding sold
1.4%

PTC Therapeutics trades, last 26 weeks

What else happened in PTC Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/20~25/03/21

Matthew B. Klein's recent trades

  • Matthew B. Klein

    Planned salePTC Therapeutics

    $705.8K

    Filed 08/04

  • Matthew B. Klein

    SellClearPoint Neuro

    $185.4K

    Filed 05/26

  • Matthew B. Klein

    Planned saleClearPoint Neuro

    $185.4K

    Filed 05/21

  • Matthew B. Klein

    Sell10b5-1 planPTC Therapeutics

    $527.7K

    Filed 05/15

  • Matthew B. Klein

    Sell10b5-1 planPTC Therapeutics

    $186.4K

    Filed 05/15

Matthew B. Klein, CEO — sold $195.2K of PTC Therapeutics PTCT · 1.4% of holdings · 10b5-1 plan | Whalegun